{"id":"https://openalex.org/W2594073619","doi":"https://doi.org/10.1016/j.ekir.2017.02.019","title":"Efficacy and Safety of Sparsentan Compared With Irbesartan in Patients With Primary Focal Segmental Glomerulosclerosis: Randomized, Controlled Trial Design (DUET)","display_name":"Efficacy and Safety of Sparsentan Compared With Irbesartan in Patients With Primary Focal Segmental Glomerulosclerosis: Randomized, Controlled Trial Design (DUET)","publication_year":2017,"publication_date":"2017-03-05","ids":{"openalex":"https://openalex.org/W2594073619","doi":"https://doi.org/10.1016/j.ekir.2017.02.019","mag":"2594073619","pmid":"https://pubmed.ncbi.nlm.nih.gov/29142983","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5678638"},"language":"en","primary_location":{"id":"doi:10.1016/j.ekir.2017.02.019","doi":"https://doi.org/10.1016/j.ekir.2017.02.019","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ekir.2017.02.019","pdf_url":"http://www.kireports.org/article/S2468024917300529/pdf","source":{"id":"https://openalex.org/S2764478277","display_name":"Kidney International Reports","issn_l":"2468-0249","issn":["2468-0249"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kidney International Reports","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://www.kireports.org/article/S2468024917300529/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071680096","display_name":"Radko Komers","orcid":"https://orcid.org/0009-0006-7814-5324","observed_orcids":["https://orcid.org/0009-0006-7814-5324"]},"institutions":[{"id":"https://openalex.org/I2802841742","display_name":"University of Massachusetts System","ror":"https://ror.org/0260j1g46","country_code":"US","type":"education","lineage":["https://openalex.org/I2802841742"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Radko Komers","raw_affiliation_strings":["Retrophin Inc, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Retrophin Inc, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I2802841742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054993212","display_name":"Debbie S. Gipson","orcid":"https://orcid.org/0000-0003-4473-9045","observed_orcids":["https://orcid.org/0000-0003-4473-9045"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Debbie S. Gipson","raw_affiliation_strings":["Division of Pediatric Nephrology, University of Michigan, Ann Arbor, Michigan, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pediatric Nephrology, University of Michigan, Ann Arbor, Michigan, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Peter Nelson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Nelson","raw_affiliation_strings":["Division of Nephrology and Kidney Research Institute, University of Washington, Seattle, Washington, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Nephrology and Kidney Research Institute, University of Washington, Seattle, Washington, USA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058716877","display_name":"Sharon G. Adler","orcid":"https://orcid.org/0000-0002-0247-3878","observed_orcids":["https://orcid.org/0000-0002-0247-3878"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I177607063","display_name":"The Lundquist Institute","ror":"https://ror.org/025j2nd68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I177607063"]},{"id":"https://openalex.org/I4210165985","display_name":"Harbor\u2013UCLA Medical Center","ror":"https://ror.org/05h4zj272","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1328359107","https://openalex.org/I4210165985"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sharon Adler","raw_affiliation_strings":["Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Los Angeles, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Los Angeles, California, USA","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I177607063","https://openalex.org/I4210165985"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108146848","display_name":"Tarak Srivastava","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1328594524","display_name":"Children's Mercy Hospital","ror":"https://ror.org/04zfmcq84","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1328594524"]},{"id":"https://openalex.org/I75421653","display_name":"University of Missouri\u2013Kansas City","ror":"https://ror.org/01w0d5g70","country_code":"US","type":"education","lineage":["https://openalex.org/I75421653"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tarak Srivastava","raw_affiliation_strings":["Children's Mercy Hospital and University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Mercy Hospital and University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA","institution_ids":["https://openalex.org/I1328594524","https://openalex.org/I75421653"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075327487","display_name":"Vimal Kumar Derebail","orcid":"https://orcid.org/0000-0002-7662-7497","observed_orcids":["https://orcid.org/0000-0002-7662-7497"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vimal K. Derebail","raw_affiliation_strings":["Division of Nephrology and Hypertension, UNC Kidney Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Nephrology and Hypertension, UNC Kidney Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082936024","display_name":"Kevin E. C. Meyers","orcid":"https://orcid.org/0000-0001-6653-269X","observed_orcids":["https://orcid.org/0000-0001-6653-269X"]},"institutions":[{"id":"https://openalex.org/I1335321130","display_name":"Children's Hospital of Philadelphia","ror":"https://ror.org/01z7r7q48","country_code":"US","type":"funder","lineage":["https://openalex.org/I1335321130"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin E. Meyers","raw_affiliation_strings":["Division of Nephrology, The Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Nephrology, The Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA","institution_ids":["https://openalex.org/I1335321130","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046497650","display_name":"Pablo E. P\u00e9rgola","orcid":"https://orcid.org/0000-0002-5876-894X","observed_orcids":["https://orcid.org/0000-0002-5876-894X"]},"institutions":[{"id":"https://openalex.org/I4210157924","display_name":"Renal Associates P. A.","ror":"https://ror.org/04wc1v131","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210157924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pablo Pergola","raw_affiliation_strings":["Renal Associates PA, San Antonio, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Renal Associates PA, San Antonio, Texas, USA","institution_ids":["https://openalex.org/I4210157924"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024771596","display_name":"Meghan E. MacNally","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802841742","display_name":"University of Massachusetts System","ror":"https://ror.org/0260j1g46","country_code":"US","type":"education","lineage":["https://openalex.org/I2802841742"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meghan E. MacNally","raw_affiliation_strings":["Retrophin Inc, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Retrophin Inc, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I2802841742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059315630","display_name":"Jennifer Leigh Hunt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802841742","display_name":"University of Massachusetts System","ror":"https://ror.org/0260j1g46","country_code":"US","type":"education","lineage":["https://openalex.org/I2802841742"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer L. Hunt","raw_affiliation_strings":["Retrophin Inc, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Retrophin Inc, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I2802841742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046187997","display_name":"Alvin Shih","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802841742","display_name":"University of Massachusetts System","ror":"https://ror.org/0260j1g46","country_code":"US","type":"education","lineage":["https://openalex.org/I2802841742"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alvin Shih","raw_affiliation_strings":["Retrophin Inc, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Retrophin Inc, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I2802841742"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029482359","display_name":"Howard Trachtman","orcid":"https://orcid.org/0000-0001-7447-9489","observed_orcids":["https://orcid.org/0000-0001-7447-9489","https://orcid.org/0009-0006-7778-292X"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Howard Trachtman","raw_affiliation_strings":["Division of Pediatric Nephrology, NYU School of Medicine, Langone Medical Center, New York, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pediatric Nephrology, NYU School of Medicine, Langone Medical Center, New York, New York, USA","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":14,"corresponding_author_ids":["https://openalex.org/A5029482359"],"corresponding_institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"],"apc_list":{"value":2800,"currency":"USD","value_usd":2800},"apc_paid":{"value":2800,"currency":"USD","value_usd":2800},"fwci":5.3796,"has_fulltext":true,"cited_by_count":49,"citation_normalized_percentile":{"value":0.95714596,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"2","issue":"4","first_page":"654","last_page":"664"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sparsentan","display_name":"sparsentan","score":0.9319999814033508},{"id":"https://openalex.org/keywords/irbesartan","display_name":"irbesartan","score":0.9959999918937683},{"id":"https://openalex.org/keywords/primary-focal-segmental-glomerulosclerosis","display_name":"primary focal segmental glomerulosclerosis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/endothelin-receptor-antagonists","display_name":"endothelin receptor antagonists","score":0.6029999852180481},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9559999704360962},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.8539999723434448},{"id":"https://openalex.org/keywords/nephrotic-syndrome","display_name":"nephrotic syndrome","score":0.8450000286102295},{"id":"https://openalex.org/keywords/urine-protein-creatinine-ratio","display_name":"urine protein-to-creatinine ratio","score":0.8529999852180481},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.6970000267028809},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6629999876022339},{"id":"https://openalex.org/keywords/end-stage-renal-disease","display_name":"end-stage renal disease","score":0.6309999823570251}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.917068600654602},{"id":"https://openalex.org/C2780259554","wikidata":"https://www.wikidata.org/wiki/Q947266","display_name":"Irbesartan","level":3,"score":0.9161824584007263},{"id":"https://openalex.org/C2778415529","wikidata":"https://www.wikidata.org/wiki/Q1435223","display_name":"Focal segmental glomerulosclerosis","level":4,"score":0.7012048363685608},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.5389116406440735},{"id":"https://openalex.org/C2779561371","wikidata":"https://www.wikidata.org/wiki/Q570197","display_name":"Proteinuria","level":3,"score":0.5272523164749146},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.5186845064163208},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.511543869972229},{"id":"https://openalex.org/C2778930706","wikidata":"https://www.wikidata.org/wiki/Q504790","display_name":"Nephrotic syndrome","level":2,"score":0.4988255500793457},{"id":"https://openalex.org/C2776345702","wikidata":"https://www.wikidata.org/wiki/Q390709","display_name":"Endothelin receptor antagonist","level":4,"score":0.4960363805294037},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47662556171417236},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.47431397438049316},{"id":"https://openalex.org/C2777390665","wikidata":"https://www.wikidata.org/wiki/Q5571239","display_name":"Glomerulosclerosis","level":4,"score":0.4614063799381256},{"id":"https://openalex.org/C144980905","wikidata":"https://www.wikidata.org/wiki/Q24721308","display_name":"Endothelin receptor","level":3,"score":0.3165864944458008},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.1530354619026184},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.09744316339492798},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07959666848182678}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1016/j.ekir.2017.02.019","doi":"https://doi.org/10.1016/j.ekir.2017.02.019","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ekir.2017.02.019","pdf_url":"http://www.kireports.org/article/S2468024917300529/pdf","source":{"id":"https://openalex.org/S2764478277","display_name":"Kidney International Reports","issn_l":"2468-0249","issn":["2468-0249"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kidney International Reports","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5678638","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5678638","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kidney Int Rep","raw_type":"Text"},{"id":"pmid:29142983","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29142983","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kidney international reports","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:0846ef0d6a47433ab1fd819f90d144be","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/0846ef0d6a47433ab1fd819f90d144be","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Kidney International Reports, Vol 2, Iss 4, Pp 654-664 (2017)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.ekir.2017.02.019","doi":"https://doi.org/10.1016/j.ekir.2017.02.019","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ekir.2017.02.019","pdf_url":"http://www.kireports.org/article/S2468024917300529/pdf","source":{"id":"https://openalex.org/S2764478277","display_name":"Kidney International Reports","issn_l":"2468-0249","issn":["2468-0249"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kidney International Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/study-protocol","display_name":"Study Protocol"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2594073619.pdf","grobid_xml":"https://content.openalex.org/works/W2594073619.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W1969653216","https://openalex.org/W1972855150","https://openalex.org/W1987380823","https://openalex.org/W1988824489","https://openalex.org/W1990585494","https://openalex.org/W1991210746","https://openalex.org/W1992543573","https://openalex.org/W1994023219","https://openalex.org/W1997966619","https://openalex.org/W2028510371","https://openalex.org/W2036692587","https://openalex.org/W2037377025","https://openalex.org/W2057349472","https://openalex.org/W2059026853","https://openalex.org/W2059769088","https://openalex.org/W2090436751","https://openalex.org/W2096179755","https://openalex.org/W2097026988","https://openalex.org/W2100732774","https://openalex.org/W2115246664","https://openalex.org/W2122257775","https://openalex.org/W2133476890","https://openalex.org/W2136089239","https://openalex.org/W2136212618","https://openalex.org/W2143078493","https://openalex.org/W2151438241","https://openalex.org/W2152298559","https://openalex.org/W2156753852","https://openalex.org/W2163543028","https://openalex.org/W2163605874","https://openalex.org/W2168448906","https://openalex.org/W2224518778","https://openalex.org/W2284026577","https://openalex.org/W2309649143","https://openalex.org/W2318427919","https://openalex.org/W2323149989","https://openalex.org/W2326576211","https://openalex.org/W2331080723","https://openalex.org/W2337907746","https://openalex.org/W2915464224","https://openalex.org/W3094568071","https://openalex.org/W4292806894"],"related_works":["https://openalex.org/W2999129752","https://openalex.org/W2898491544","https://openalex.org/W2617438993","https://openalex.org/W4388302906","https://openalex.org/W4229027438","https://openalex.org/W4395672610","https://openalex.org/W7203834484","https://openalex.org/W4407863268","https://openalex.org/W2955153223","https://openalex.org/W4396991461"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Primary":[1],"focal":[2],"segmental":[3],"glomerulosclerosis":[4],"(FSGS)":[5],"is":[6,36,49,69,94,142,161],"a":[7,50,84,95],"leading":[8],"cause":[9],"of":[10,43,112,190,196,216],"nephrotic":[11],"syndrome":[12],"and":[13,22,28,59,82,202,205,221,237,248],"end-stage":[14],"renal":[15],"disease.":[16],"There":[17],"are":[18],"no":[19],"US":[20],"Food":[21],"Drug":[23],"Administration-approved":[24],"therapies":[25],"for":[26,134,246,253],"FSGS,":[27],"treatment":[29,129],"often":[30],"fails":[31],"to":[32,71,119,128,143,163,177],"reduce":[33],"proteinuria.":[34],"Endothelin":[35],"an":[37,79,103,242],"important":[38,231],"factor":[39],"in":[40,88,168,200],"the":[41,145,150,170,184,188,214,217,251],"pathophysiology":[42],"podocyte":[44],"disorders,":[45],"including":[46],"FSGS.":[47,91],"Sparsentan":[48],"first-in-class,":[51],"orally":[52],"active,":[53],"dual-acting":[54],"angiotensin":[55],"receptor":[56,65],"blocker":[57],"(ARB)":[58],"highly":[60],"selective":[61],"endothelin":[62,238],"Type":[63],"A":[64],"antagonist.":[66],"This":[67,227],"study":[68,101,228],"designed":[70],"evaluate":[72,187],"whether":[73,234],"sparsentan":[74,114,131,148],"lowers":[75],"proteinuria":[76],"compared":[77],"with":[78,90,102,122,130],"ARB":[80,236],"alone":[81],"has":[83],"favorable":[85],"safety":[86,207],"profile":[87],"patients":[89,191],"METHODS:":[92],"DUET":[93],"phase":[96],"2,":[97],"randomized,":[98],"active-control,":[99],"dose-escalation":[100],"8-week,":[104],"fixed-dose,":[105],"double-blind":[106,218],"period":[107],"followed":[108],"by":[109],"136":[110],"weeks":[111,179],"open-label":[113,222],"treatment.":[115],"Patients":[116],"aged":[117],"8":[118,135,178],"75":[120],"years":[121],"primary":[123,139],"FSGS":[124,247],"will":[125,186,210,229],"be":[126,211,241],"randomized":[127],"or":[132,157],"irbesartan":[133,164],"weeks.":[136],"RESULTS:":[137],"The":[138],"efficacy":[140],"objective":[141],"test":[144],"hypothesis":[146],"that":[147],"over":[149],"dose":[151],"range":[152],"(200":[153],"mg,":[154,156],"400":[155],"800":[158],"mg":[159,166],"daily)":[160,167],"superior":[162],"(300":[165],"decreasing":[169],"urinary":[171],"protein-to-creatinine":[172],"ratio":[173],"(UPC)":[174],"from":[175],"baseline":[176],"postrandomization.":[180],"As":[181],"secondary":[182],"objectives,":[183],"trial":[185],"proportion":[189],"who":[192],"achieve":[193],"prespecified":[194],"targets":[195],"UPC":[197],"reduction,":[198],"changes":[199],"laboratory":[201],"quality-of-life":[203],"indices,":[204],"detailed":[206],"analysis.":[208],"Analyses":[209],"conducted":[212],"at":[213],"end":[215],"(week":[219,223],"8)":[220],"144)":[224],"periods.":[225],"DISCUSSION:":[226],"provide":[230,250],"evidence":[232],"on":[233],"dual":[235],"blockade":[239],"may":[240,249],"effective":[243],"therapeutic":[244],"strategy":[245],"rationale":[252],"next-phase":[254],"trials.":[255]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":14},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2017-03-16T00:00:00"}